Andrew D Davidson
Overview
Explore the profile of Andrew D Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
3315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Webb I, Erdmann M, Milligan R, Savage M, Matthews D, Davidson A
J Gen Virol
. 2025 Feb;
106(2).
PMID: 39937571
The SARS-CoV-2 genome encodes at least nine accessory proteins, including innate immune antagonist and putative viroporin ORF3a. ORF3a plays a role in many stages of the viral replication cycle, including...
2.
Erdmann M, Hodgson L, Webb I, Davidson A, Verkade P
Methods Cell Biol
. 2024 May;
187:99-116.
PMID: 38705632
Correlative Light Electron Microscopy (CLEM) is a powerful technique to investigate the ultrastructure of specific cells and organelles at sub-cellular resolution. Transmission Electron Microscopy (TEM) is particularly useful to the...
3.
Haddrell A, Oswin H, Otero-Fernandez M, Robinson J, Cogan T, Alexander R, et al.
Nat Commun
. 2024 Apr;
15(1):3487.
PMID: 38664424
An improved understanding of the underlying physicochemical properties of respiratory aerosol that influence viral infectivity may open new avenues to mitigate the transmission of respiratory diseases such as COVID-19. Previous...
4.
Bigotti M, Klein K, Gan E, Anastasina M, Andersson S, Vapalahti O, et al.
Antiviral Res
. 2024 Feb;
224:105837.
PMID: 38387750
The COVID-19 pandemic has shown the need to develop effective therapeutics in preparedness for further epidemics of virus infections that pose a significant threat to human health. As a natural...
5.
Buzas D, Bunzel A, Staufer O, Milodowski E, Edmunds G, Bufton J, et al.
Antib Ther
. 2023 Dec;
6(4):277-297.
PMID: 38075238
Background: Due to COVID-19, pandemic preparedness emerges as a key imperative, necessitating new approaches to accelerate development of reagents against infectious pathogens. Methods: Here, we developed an integrated approach combining...
6.
Gallucci L, Bazire J, Davidson A, Shytaj I
Antiviral Res
. 2023 Dec;
221:105766.
PMID: 38042417
Coronaviruses pose a permanent risk of outbreaks, with three highly pathogenic species and strains (SARS-CoV, MERS-CoV, SARS-CoV-2) having emerged in the last twenty years. Limited antiviral therapies are currently available...
7.
Stewart H, Lu Y, OKeefe S, Valpadashi A, Cruz-Zaragoza L, Michel H, et al.
iScience
. 2023 Oct;
26(11):108080.
PMID: 37860693
The SARS-CoV-2 genome encodes a multitude of accessory proteins. Using comparative genomic approaches, an additional accessory protein, ORF3c, has been predicted to be encoded within the ORF3a sgmRNA. Expression of...
8.
Haddrell A, Otero-Fernandez M, Oswin H, Cogan T, Bazire J, Tian J, et al.
J R Soc Interface
. 2023 Jun;
20(203):20230062.
PMID: 37340783
The mechanistic factors hypothesized to be key drivers for the loss of infectivity of viruses in the aerosol phase often remain speculative. Using a next-generation bioaerosol technology, we report measurements...
9.
Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, et al.
Elife
. 2023 Jun;
12.
PMID: 37310006
Coronavirus disease-19 (COVID-19) causes immune perturbations which may persist long term, and patients frequently report ongoing symptoms for months after recovery. We assessed immune activation at 3-12 months post hospital...
10.
Wing P, Schmidt N, Peters R, Erdmann M, Brown R, Wang H, et al.
PLoS Pathog
. 2023 May;
19(5):e1011323.
PMID: 37134108
The severity of disease following infection with SARS-CoV-2 is determined by viral replication kinetics and host immunity, with early T cell responses and/or suppression of viraemia driving a favourable outcome....